| Logo | Name | Σ |
|---|---|---|
 | Retis Retis is the French network of innovation professionals at the service of innovative companies and territories with the missions: - the professionalization of members through the qualification of employees and the certification of organizations - Lobbying and network animation - the experimentation of pilot projects dedicated to innovative entrepreneurship at the national and international level Complementary links of the same chain of network innovation, The members of the RETIS network support the creation and development of innovative companies in the territories with two missions and Complementary trades - support for these innovative companies - the animation of their territory and … | 274 |
 | Boehringer Ingelheim Our people are our strength. And, together with over 54,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Privacy Notice: https://www.boehringer-ingelheim.com/privacy-notice Imprint: https://www.boehringer-ingelheim.com/imprint Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing Sectors: Animal Health Pharmaceutical | 1964 |
 | Business France Business France is the national agency for the internationalization of the French economy. It is responsible for the international development of companies and their exports, as well as prospecting for and welcoming international investments in France. It promotes the attractiveness and business image of France, its companies and its territories. It manages and develops the V.I.E (Volontariat International en Entreprise). Created on January 1, 2015, Business France is a merger of UBIFRANCE and the AFII (French Agency for International Investments). Business France has 1,500 employees located in France and in 70 countries. It relies on a network of public and … Sectors: National and local authorities | 5598 |
 | Sifted The leading media brand empowering startup Europe | Backed by the Financial Times. Sifted is the critical friend of the European startup ecosystem – providing startup founders, senior management teams, investors and service providers with the curated insights, in-depth analysis and networking opportunities they need to grow their business. Whatever your role is within the ecosystem, however you like to stay up to speed, we've got something for you: 🗞️ Sifted Daily: Our daily newsletter is the essential morning read for founders, investors and corporates who want a quick digest of the news that matters 🔎 Sifted Pro: Our premium … | 2655 |
 | Novo Nordisk Get updates around our progress and challenges to champion long-term health 💙 #DrivingChange Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments … Sectors: Pharmaceutical | 1476 |
 | AstraZeneca We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business Sectors: Pharmaceutical | 3926 |
 | Alexion Pharmaceuticals, Inc. Transforming Lives, Every Day. Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex … Sectors: Biotechnology Pharmaceutical | 274 |